1. Home
  2. NRIX vs GIC Comparison

NRIX vs GIC Comparison

Compare NRIX & GIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRIX
  • GIC
  • Stock Information
  • Founded
  • NRIX 2009
  • GIC 1949
  • Country
  • NRIX United States
  • GIC United States
  • Employees
  • NRIX N/A
  • GIC N/A
  • Industry
  • NRIX Biotechnology: Pharmaceutical Preparations
  • GIC Industrial Machinery/Components
  • Sector
  • NRIX Health Care
  • GIC Industrials
  • Exchange
  • NRIX Nasdaq
  • GIC Nasdaq
  • Market Cap
  • NRIX 1.3B
  • GIC 1.1B
  • IPO Year
  • NRIX 2020
  • GIC 1995
  • Fundamental
  • Price
  • NRIX $19.83
  • GIC $25.34
  • Analyst Decision
  • NRIX Strong Buy
  • GIC
  • Analyst Count
  • NRIX 17
  • GIC 0
  • Target Price
  • NRIX $30.29
  • GIC N/A
  • AVG Volume (30 Days)
  • NRIX 988.4K
  • GIC 101.4K
  • Earning Date
  • NRIX 02-13-2025
  • GIC 10-29-2024
  • Dividend Yield
  • NRIX N/A
  • GIC 3.97%
  • EPS Growth
  • NRIX N/A
  • GIC N/A
  • EPS
  • NRIX N/A
  • GIC 1.71
  • Revenue
  • NRIX $56,424,000.00
  • GIC $1,333,700,000.00
  • Revenue This Year
  • NRIX N/A
  • GIC $4.92
  • Revenue Next Year
  • NRIX $3.79
  • GIC $3.66
  • P/E Ratio
  • NRIX N/A
  • GIC $14.82
  • Revenue Growth
  • NRIX N/A
  • GIC 9.80
  • 52 Week Low
  • NRIX $7.65
  • GIC $25.01
  • 52 Week High
  • NRIX $29.56
  • GIC $46.97
  • Technical
  • Relative Strength Index (RSI)
  • NRIX 38.42
  • GIC 25.02
  • Support Level
  • NRIX $19.38
  • GIC $25.11
  • Resistance Level
  • NRIX $21.67
  • GIC $28.07
  • Average True Range (ATR)
  • NRIX 1.34
  • GIC 0.66
  • MACD
  • NRIX 0.00
  • GIC -0.16
  • Stochastic Oscillator
  • NRIX 12.61
  • GIC 7.43

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. It distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

Share on Social Networks: